BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25270282)

  • 21. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer.
    Chen P; Xi Q; Wang Q; Wei P
    Med Oncol; 2014 Oct; 31(10):235. PubMed ID: 25216869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between miR-21 and miR-145 and the incidence and prognosis of colorectal cancer.
    Liu Q; Yang W; Luo Y; Hu S; Zhu L
    J BUON; 2018; 23(1):29-35. PubMed ID: 29552756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
    Huang Y; Xiao W; Jiang X; Li H
    Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
    Rapti SM; Kontos CK; Papadopoulos IN; Scorilas A
    Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis.
    Li X; Yang C; Wang X; Zhang J; Zhang R; Liu R
    Med Oncol; 2014 Jan; 31(1):781. PubMed ID: 24293092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
    Zhang N; Zhang PP; Huang JJ; Wang ZY; Zhang ZH; Yuan JZ; Ma EM; Liu X; Bai J
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):664-672. PubMed ID: 32016967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.
    Toiyama Y; Takahashi M; Hur K; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    J Natl Cancer Inst; 2013 Jun; 105(12):849-59. PubMed ID: 23704278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
    Yuan D; Li K; Zhu K; Yan R; Dang C
    Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-630 is a prognostic marker for patients with colorectal cancer.
    Chu D; Zheng J; Li J; Li Y; Zhang J; Zhao Q; Wang W; Ji G
    Tumour Biol; 2014 Oct; 35(10):9787-92. PubMed ID: 24981248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TEAD4 nuclear localization and regulation by miR-4269 and miR-1343-3p in colorectal carcinoma.
    Bhat IP; Rather TB; Bhat GA; Maqbool I; Akhtar K; Rashid G; Parray FQ; Besina S; Mudassar S
    Pathol Res Pract; 2022 Mar; 231():153791. PubMed ID: 35124548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.
    Yang L; Men WL; Yan KM; Tie J; Nie YZ; Xiao HJ
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4837-4845. PubMed ID: 30070320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease.
    Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
    Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
    Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
    Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Significance of microRNA-7 and its Roles in the Regulation of Cisplatin Resistance in Lung Adenocarcinoma.
    Cheng MW; Shen ZT; Hu GY; Luo LG
    Cell Physiol Biochem; 2017; 42(2):660-672. PubMed ID: 28618418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
    Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S
    Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of miR-720 prognostic significance in patients with colorectal cancer.
    Wang X; Kuang Y; Shen X; Zhou H; Chen Y; Han Y; Yuan B; Zhou J; Zhao H; Zhi Q; Xue X
    Tumour Biol; 2015 Feb; 36(2):719-27. PubMed ID: 25286763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of NF-E1b in colorectal cancer tissues and its clinical significance].
    Xu K; Chen L; Di J; Wang Z; Wang A; Wu W; Wu F; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):685-9. PubMed ID: 27353105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer.
    Ma YB; Li GX; Hu JX; Liu X; Shi BM
    Genet Mol Res; 2015 Dec; 14(4):18153-9. PubMed ID: 26782462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.